Komori
Financial results presentation4275Carlit Co.,Ltd.Materials and Chemicals

Notice of Publication and Video Webcast of the Financial Results Briefing for the Fiscal Year Ending March 2026 (with Q&A Added)

Revenue declined in the fiscal year ended March 2026, but operating income, ordinary income and net income all increased, mainly due to lower costs of sales and SG&A expenses. For the fiscal year ending March 2027, revenue and net income are expected to increase, while operating income and ordinary income are forecast to decline.

Worth reading
72In focus
Scored from 5 of 6 sections
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
412
Millions of yen (year-on-year increase in operating profit)
Wording
Avoiding a definitive answer
How definitive the wording is.

Contents of this document

Financial results presentationFiscal year ending March 2026, full year10 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥36,247 million-1.8%
Operating profit¥3,459 million+13.5%
Ordinary income¥3,755 million+13.1%
Net income¥2,976 million+15.8%
Selling, general and administrative expenses¥6,073 million
Full-year earnings forecast
Net Sales
¥37,200 million
Operating profit
¥3,200 million
Ordinary income
¥3,300 million
Net income
¥3,000 million
Year-end dividend
¥42 per share
What the company explained in this material
Key points of the Q&AKey questions raised by investors at the briefing and the company's answers
  1. The impact of the situation in the Middle East, crude oil and naphtha shortages is not reflected in the earnings forecast, but the Company aims to offset higher raw material prices through appropriate pricing.
  2. Growth drivers for the Chemicals segment are higher demand for and pricing of AP, electronic materials for high-end servers, and a recovery in automobile demand.
  3. Construction costs for manufacturing facilities for solid propellants for defense applications are planned to be funded through initial costs borne by the Ministry of Defense.
  4. Following the bottling equipment upgrade, the Company expects to expand its product lineup, customer base and orders.
  5. No major changes to the business portfolio are planned during the Challenge2027 period.
  6. The Company decided not to present specific profit targets for 2030 and 2035 because the external environment is unstable.
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
The presentation identifies uncertainty and higher costs in procuring fuel and raw materials arising from the situation in the Middle East as assumptions and risks. It also notes year-on-year volume growth for sodium chlorate, but specific figures are Not disclosed.
New initiatives
  • Upgrade the bottling PET line from the hot-fill method to the aseptic method
  • Invest in facilities to increase ammonium perchlorate production
  • Develop manufacturing facilities for solid propellants for defense applications and plan a new plant scheduled for completion in fiscal 2027
  • Mass production of solid propellants, and research and development of proprietary propellants and adjacent fields
  • One-on-one meetings, talent management and work-style initiatives to improve employee engagement
Key KPIsA metric the company considers important as a management benchmark.
  • PBR1.42 times
    Year on year against the same period last yearImproved from 0.66 times in the fiscal year ended March 2025
  • ROE7.7 %
    Year on year against the same period last yearImproved from 6.9% in the fiscal year ended March 2025
  • Employee Engagement63.5 %
Segment results
Chemicals
Net Sales
¥21,977 million-2.0%
Operating profit
¥1,858 million+25.7%
Bottling
Net Sales
¥4,480 million-1.0%
Operating profit
¥378 million+9.6%
Metal Processing
Net Sales
¥7,303 million+1.0%
Operating profit
¥602 million+18.5%
Engineering Services
Net Sales
¥5,251 million+19.0%
Operating profit
¥795 million-3.3%
Medium-term management plan targets
Final year of Challenge2027
Operating profit
¥4,200 million
ROE
8.5 %
PBR
2 times or more
Space and Defense Business, fiscal 2035
Net Sales
¥9,500 million
Financial targets
ROE
Target value8.5 %
Actual value7.7 %
PBR
Target value2 times or more
Actual value1.42 times or more
Capital expenditures
¥210 100 million total capital investment for fiscal 2025–2027
Annual Dividend
¥42 per share
End of period42
Acquisition of treasury shares
¥1 billion in May 2025, ¥500 million in November 2025 and ¥1 billion in May 2026. The number of shares and acquisition periods are Not disclosed.
Contents of this document
ItemDetails
Document typeFinancial results presentation
Fiscal Period CoveredFiscal year ending March 2026, full year
Net Sales¥36,247 million (YoY -1.8%)
Operating profit¥3,459 million (YoY +13.5%)
Ordinary income¥3,755 million (YoY +13.1%)
Net income¥2,976 million (YoY +15.8%)
Selling, general and administrative expenses¥6,073 million
Full-year earnings forecastNet Sales ¥37,200 million / Operating profit ¥3,200 million / Ordinary income ¥3,300 million / Net income ¥3,000 million / Year-end dividend ¥42 per share
Segment resultsChemicals Net Sales ¥21,977 million (YoY -2.0%) / Operating profit ¥1,858 million (YoY +25.7%) / Bottling Net Sales ¥4,480 million (YoY -1.0%) / Operating profit ¥378 million (YoY +9.6%) / Metal Processing Net Sales ¥7,303 million (YoY +1.0%) / Operating profit ¥602 million (YoY +18.5%) / Engineering Services Net Sales ¥5,251 million (YoY +19.0%) / Operating profit ¥795 million (YoY -3.3%)
Key KPIsIndicator name PBR / Value 1.42 times / Year on year against the same period last year Improved from 0.66 times in the fiscal year ended March 2025, Indicator name ROE / Value 7.7 % / Year on year against the same period last year Improved from 6.9% in the fiscal year ended March 2025, Indicator name Employee Engagement / Value 63.5 % / Year on year against the same period last year Not disclosed
Assumptions Underlying the Business OutlookThe presentation identifies uncertainty and higher costs in procuring fuel and raw materials arising from the situation in the Middle East as assumptions and risks. It also notes year-on-year volume growth for sodium chlorate, but specific figures are Not disclosed.
Medium-term management plan targetsFinal year of Challenge2027 Operating profit ¥4,200 million / ROE 8.5 % / PBR 2 times or more / Space and Defense Business, fiscal 2035 Net Sales ¥9,500 million
Financial targetsROE Target value 8.5 % / Actual value 7.7 % / PBR Target value 2 times or more / Actual value 1.42 times or more
Annual Dividend¥42 per share
Acquisition of treasury shares¥1 billion in May 2025, ¥500 million in November 2025 and ¥1 billion in May 2026. The number of shares and acquisition periods are Not disclosed.
Capital expenditures¥210 100 million (total capital investment for fiscal 2025–2027)
Key points of the Q&AThe impact of the situation in the Middle East, crude oil and naphtha shortages is not reflected in the earnings forecast, but the Company aims to offset higher raw material prices through appropriate pricing., Growth drivers for the Chemicals segment are higher demand for and pricing of AP, electronic materials for high-end servers, and a recovery in automobile demand., Construction costs for manufacturing facilities for solid propellants for defense applications are planned to be funded through initial costs borne by the Ministry of Defense., Following the bottling equipment upgrade, the Company expects to expand its product lineup, customer base and orders., No major changes to the business portfolio are planned during the Challenge2027 period., The Company decided not to present specific profit targets for 2030 and 2035 because the external environment is unstable.
New initiativesUpgrade the bottling PET line from the hot-fill method to the aseptic method, Invest in facilities to increase ammonium perchlorate production, Develop manufacturing facilities for solid propellants for defense applications and plan a new plant scheduled for completion in fiscal 2027, Mass production of solid propellants, and research and development of proprietary propellants and adjacent fields, One-on-one meetings, talent management and work-style initiatives to improve employee engagement
Items this document does not state (13)
Gross Profit MarginOperating profit marginResults for the three months of the current quarterProgress against full-year forecastSelf-assessment against the planBreakdown of Factors Affecting the ChangeUnit price and quantity metricsNumber of stores and locationsNumber of employeesRisk amount incorporated into the outlookPayout ratioOrders received and order backlogMarket Size / Share

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

In the fiscal year ended March 2026, lower SG&A expenses, the implementation of appropriate pricing, cost reductions and productivity improvements boosted earnings. Meanwhile, lower demand, a slowdown in EV demand, adjustments by certain customers and higher costs for raw materials and energy contributed to the decline in revenue and earnings. For the fiscal year ending March 2027, the Company expects uncertainty and higher costs in procuring fuel and raw materials due to the situation in the Middle East, as well as an impact from construction to upgrade bottling equipment.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Publication and Video Webcast of the Financial Results Briefing for the Fiscal Year Ending March 2026 (with Q&A Added) | Carlit Co.,Ltd. (4275) timely disclosure | Komori